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Specialized niche environments specify andmaintain
stem and progenitor cells, but little is known about
the identities and functional interactions of niche
components in vivo. Here, we describe a modular
system for the generation of artificial thymopoietic
environments in the mouse embryo. Thymic epithe-
lium that lacks hematopoietic function but is physio-
logically accessible for hematopoietic progenitor
cells is functionalized by individual and combinato-
rial expression of four factors, the chemokines
Ccl25 and Cxcl12, the cytokine Scf, and the Notch
ligand DLL4. The distinct phenotypes and variable
numbers of hematopoietic cells in the resulting
epithelial environments reveal synergistic, context-
dependent, and hierarchical interactions among
effector molecules. The surprisingly simple rules
determining hematopoietic properties enable the
in vivo engineering of artificial environments con-
ducive to the presence of distinct myeloid or T or B
lymphoid lineage precursors; moreover, synthetic
environments facilitate the procurement of physio-
logical progenitor cell types for analytical purposes
and future therapeutic applications.INTRODUCTION
Specialized niches for stem cells and progenitor cells are essen-
tial for tissue maintenance and regeneration in multicellular
organisms (Butler et al., 2010; Chan et al., 2009; Gilbert et al.,
2010; Sato et al., 2011; Scadden, 2006; Schofield, 1978; Yama-
zaki et al., 2011). Although some of the cell types and the mole-
cules that constitute such niches have been identified, little is
known about the functional interactions of these factors in the
intact organism. For instance, nestin-expressing mesenchymal
stem cells, bone-lining osteoblasts, Cxcl12-expressing reticular
cells, and phagocytes cooperate to generate the cellular niche
environment of hematopoietic stem cells under steady-state
conditions and possibly also in response to injury or physiolog-ical regulation; among the plethora of factors that are thought
to be important for niche function are chemokines (such as
Cxcl12), cytokines (such as stem cell factor, Scf), and Notch
ligands (Ehninger and Trumpp, 2011; Voog and Jones, 2010).
As a result of the experimental difficulties in examining the
complex interplay of different cell types and effector molecules,
the functional interactions and relative importance of niche
effector molecules in vivo remain largely enigmatic. Indeed,
examining these questions by classical loss-of-function
approaches is essentially impractical, as it would involve the
creation of dauntingly complex compound genotypes. Here,
we propose the generation, by in vivo engineering, of synthetic
hematopoietic environments as a conceptual alternative to study
the functional networks of effector molecules.
Ideally, the target tissue of in vivo genetic engineering should
be physiologically accessible for progenitor cells yet lack hema-
topoietic function. In the normal mouse, no tissue fulfills these
requirements; we reasoned, however, that this obstacle could
be overcome by targeting a dysfunctional hematopoietic
microenvironment. In the mouse embryo, the two major sites
of hematopoietic activity are the fetal liver and the thymus.
Whereas the former consists of a complex tissue microenviron-
ment (Charbord et al., 2002) not unlike the bone marrow, the
microenvironment of the thymus comprises mainly epithelial
cells, the developmental characteristics of which are well known
(Anderson et al., 2006). In the embryonic phase of mouse devel-
opment all hematopoietic sites, including the thymus, have
access via the blood stream to a diverse range of blood-borne
hematopoietic progenitors that are generated by the fetal liver
(Kawamoto et al., 2000; Rodewald, 1995). The number and
phenotype of hematopoietic cells in the thymus can be precisely
determined because the thymic anlage is an anatomically well-
defined and circumscribed structure. However, the exact nature
and physiological potential of progenitor cells homing to the
thymus are a matter of debate (Kawamoto and Katsura, 2009;
Schlenner and Rodewald, 2010). Remarkably, the hematopoietic
capacity of the thymus depends on the activity of the transcrip-
tion factor Foxn1 (Nehls et al., 1994), which is expressed in
thymic epithelial cells (Corbeaux et al., 2010; Terszowski et al.,
2006); hence, in Foxn1-deficient animals no hematopoietic cells
are found in the thymus (Blackburn et al., 1996; Nehls et al.,
1996), although their progenitors are produced normally (Wortis
et al., 1971). The functional categories of target genes of theCell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc. 159
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Figure 1. Dysfunctional Epithelial Environment in Foxn1-Deficient Embryos
(A) The expression of genes encoding chemokines, cytokine and Notch ligand is specifically absent in Foxn1/ thymic epithelia (E13.5 embryos); the gene-
specific probes used for RNA in situ hybridization (blue color indicates positive signal) are indicated at the top; oe, esophagus, tr, trachea, thymic lobes are
outlined with dashed lines. Scale bars, 200 mm.
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Foxn1 transcription factor comprise chemokines (Bajoghli et al.,
2009; Bleul and Boehm, 2000), cytokines (below), and Notch
ligands (Bajoghli et al., 2009; Tsukamoto et al., 2005), suggesting
that their cooperative interplay contributes to the remarkably
potent hematopoietic activity in this tissue environment. This
characteristic suggests that, for thymic epithelial cells, the
reduction of a complex and idiosyncratic cellular hematopoietic
environment to a dysfunctional ground state is experimentally
feasible. Subsequently, the Foxn1-deficient thymic epithelium
can be refunctionalized in a stepwise fashion because it was
previously shown that the promoter elements of the Foxn1
gene direct tissue-specific expression of transgenes (Boehm,
2008).
Based on these considerations, we chose the epithelium of
the embryonic thymus anlage for the creation of artificial
hematopoietic environments. These studies revealed the rules
of functional interactions of effector molecules and enabled us
to create in vivo environments conducive to the presence of
different myeloid and lymphoid precursor cell types.
RESULTS
Functional Characteristics of the Dysfunctional Ground
State of Foxn1-Deficient Epithelium
Hematopoietic environments attract progenitor cells, for
instance via the action of chemokines; they also provide survival
factors and supply specification signals in order to maintain or
induce distinct cell fates.
In the thymic epithelium, the expression of several key regula-
tors of hematopoiesis of these three categories is controlled
by the Foxn1 transcription factor. Hence, in the absence of
Foxn1, the hematopoietic activity of the thymic epithelium
ceases. In particular, expression of the genes encoding the
chemokines Ccl25 and Cxcl12 cannot be detected in the
Foxn1-deficient thymic epithelium (Figure 1A). Both chemokines
regulate the hematopoietic precursor homing process (Caldero´n
and Boehm, 2011); Cxcl12 serves additional functions during
lymphoid development (Janas et al., 2010; Nagasawa, 2000;
Trampont et al., 2010). In addition, the gene encoding the
cytokine Scf (also known as Kit ligand) is not expressed in the
Foxn1-deficient epithelium (Figure 1A), whereas the expression(B) Distribution of CD45+ hematopoietic cells (red fluorescence) in epithelial tissue
13.5 of nontransgenic embryos of the indicated genotypes. oe, esophagus, tr, tr
(C) Enumeration and phenotypic characterization of hematopoietic cells in thym
mean ± standard error of the mean (SEM).
(D) Re-expression of Ccl25, Cxcl12, DLL4, and Scf genes in the Foxn1/ thymic
driven transgenes (gene-specific probes are indicated at the top of panels) in thym
are nontransgenic Foxn1/ controls, the right panels correspond to the transge
(E) Distribution of CD45+ hematopoietic cells (red) in the pharynx of E13.5–E14.5 t
tissues are detected by cytokeratin (CK8) staining (green); the relevant transgenes
(F) Distribution of CD45+ hematopoietic cells (red) in the epithelium (green) of E1
(G and H) Enumeration (G) and phenotypic characterization by flow cytometry (H
E18.5 embryos. In (G), the genotypes are indicated at the bottom; + denotes pre
significant differences from the values of nontransgenic controls (t test; *p < 0.0
in Cxcl12 transgenics, the difference to the nontransgenic control is not significa
embryos only, causing high variance for the entire group of embryos with this ge
f denotes nontransgenic tissues. Average values and SEM values are shown. D
groups. Figure S1 relates to this figure.of the gene for another cytokine, Il7, is still present (Soza-Ried
et al., 2008; Zamisch et al., 2005). Finally, whereas the genes
encoding various Notch ligands are expressed in the thymic
epithelium, the expression of Dll4 is specifically absent in mutant
tissue (Figure 1A; Figure S1A available online). It is assumed, but
so far unproved, that the combined (rather than individual)
absence of these effectors is the reason for the complete
abrogation of hematopoietic capacity in the thymus of Foxn1-
deficient animals. Although CD45+ hematopoietic progenitors
develop normally in Foxn1-deficient embryos (Wortis et al.,
1971), they are not found in the nonfunctional thymic epithelium,
although some are located in its vicinity (Figure 1B). Therefore,
shortly before birth (at embryonic day [E] 18.5), only about
250 CD45+ hematopoietic cells per embryo can be recovered
from microdissected thymic rudiments of Foxn1-deficient
embryos (Figure 1C). In contrast to wild-type thymi, the Foxn1-
deficient rudiments are not vascularized and lack mesenchymal
septae, whereas the hematopoietic cells located inside the
wild-type thymi proliferate vigorously, CD45+ cells in the vicinity
of the Foxn1-deficient thymic lobes do not (Figure S1B).
Transgenic Refunctionalization of the Foxn1-Deficient
Thymic Epithelium
The Foxn1-deficient thymic epithelium is amenable to specific
transgenic modification, using the Foxn1 promoter elements
that control spatially and temporally faithful expression of
transgenes in the epithelium (Boehm, 2008). We exploited this
unique situation to re-express Ccl25, Cxcl12, Scf, and DLL4 in
Foxn1-deficient epithelial cells (Figures 1D and S1C–S1E). The
separate expression of three of the four Foxn1 target genes in
the epithelium had measurable effects on the occurrence of
hematopoietic cells in and around the thymic rudiment. In the
presence of either Ccl25, Cxcl12, or Scf, CD45+ cells were
now found within the transgenic thymic rudiments, suggesting
that Ccl25, Cxcl12, and Scf have chemotactic functions; by
contrast, expression of the Notch ligand DLL4 did not induce
hematopoietic activity (Figures 1E and 1F). Under the first
three conditions, the number of CD45+ cells that could be iso-
lated from the thymic lobes approximately doubled (Figure 1G).
Although numerical increases were small, the composition of
cell types nonetheless significantly changed in amanner specifics (cytokeratin 8 [CK8], green fluorescence) of the pharynx at embryonic day (E)
achea, th, thymic lobes. Scale bars, 100 mm.
ic epithelial rudiments (Foxn1/, n = 45 animals; Foxn1+/, n = 8 animals);
epithelium. RNA in situ hybridizations detect transcripts from Foxn1-promoter
ic rudiments at E16.5 (encircled with dotted lines); the left panels of each pair
nic tissues. Scale bars, 100 mm.
ransgenic Foxn1/ embryos; for a control Foxn1+/ embryo, see (B). Epithelial
are indicated. oe, esophagus; tr, trachea; th, thymic lobes. Scale bars, 100 mm.
6.5 thymic lobes. Notation as in (A), (B), and (E). Scale bars, 50 mm.
) of hematopoietic cells in the thymic lobes of nontransgenic and transgenic
sence of transgene; n denotes number of embryos analyzed; asterisks denote
5; **p < 0.01; ***p < 0.001). Although there is a clear increase in CD19+ cells
nt; this is due to the fact that increased CD19+ cells occur in about half of the
notype. In (H), genotypes are indicated at the top.
unn’s nonparametric multiple t test was used to examine differences between
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for each factor. The presence of the chemokine Ccl25 led to an
increase in cells of the lymphocyte lineages in the thymic niche,
the expression of Cxcl12 caused an increase mainly in CD19+ B
lineage cells, and the expression of Scf led to an increase in
a CD11bCD19CD90 cell population (Figures 1G and 1H).
The distinct effects of these factors demonstrate the modular
nature of their functions.
Combinatorial Expression of Stromal Effector
Molecules
In contrast to the modest changes observed after expression
of each single factor, their combinatorial expression more
profoundly affected the composition of cells in the resulting 11
different transgenic stromal microenvironments, both in terms
of numbers (Figure 2A) and phenotypes (Figure 2B) of CD45+
hematopoietic cells. Each combination also led to a distinct
pattern of accumulation of CD45+ cells in and around the thymic
rudiments. Two general patterns emerge: in the first type, CD45+
cells mostly collect around the thymic anlagen, with few cells
situated within the epithelial rudiment; in the second type,
intraepithelial accumulation is more prominent (Figures 2C and
2D). The phenotypic and functional characteristics of hemato-
poietic cells in environments expressing specific combinations
of effector molecules are detailed below.
Mast Cell Environment
In Ccl25;Scf double-transgenics, numerous CD45+ cells
were detected within the epithelial tissue (Figures 2C, 2D,
and 3A), the majority of which possessed the CD11b
CD19CD90CD117+ST2+ surface phenotype (Figures 3B and
3C). These cells contain basophilic cytoplasmic granules (Fig-
ure 3D), actively proliferate (Figure 3E), are mostly negative for
FcεRIa, and express intermediate levels of CD117 (Figure 3F),
identifying them as immature mast cells (Moritz et al., 1998).
Mast cell progenitors were previously identified in fetal blood
(Rodewald et al., 1996). Thus, the simultaneous expression of
Ccl25 and Scf generates an environment favorable for mast
cell progenitors, as does the expression of Scf alone, albeit
less efficiently (Figures 3A and 3C). The mast cell progenitors
mature further in the transgenic lobes upon in vitro culture as
indicated by increased levels of FcεRIa and CD117 surface
expression and increased granularity (Figure 3G). This observa-
tion not only illustrates synergy between Ccl25 and Scf but also
shows how an anatomically circumscribed tissue can be con-
verted into a cell type-specific environment. These data also
point to minimum components for the still elusive endogenous
mast progenitor cell niches (Chen et al., 2005).
B Cell Progenitor Environment
Although the Ccl25;Scf transgenic environment mainly con-
tained myeloid cells, additional expression of Cxcl12 generated
a lymphopoietic niche. Indeed, the massive increase in hemato-
poietic cells caused by the simultaneous expression of Ccl25,
Cxcl12, and Scf (Figures 2C, 2D, and 4A) is almost entirely due
to the presence of CD19+ B lineage cells (Figures 4A–4C).
Even with combinations of Ccl25 and Cxcl12, as well as Scf
and Cxcl12, B lineage cells predominate (Figure 4A), although
the numbers were lower than in triple-transgenic epithelia.162 Cell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc.Owing to the lack of surface IgM, these cells were identified
as early B cells (CD19+B220+IgM) (Figure 4C), most of which
actively proliferate (Figure 4D). When Ccl25;Cxcl12;Scf triple-
transgenic thymic lobes were cultured in vitro, the resident B
cells readily differentiated into mature B cells (coexpressing
IgM and IgD at the surface; Figure 4E). Accordingly, the gene
expression signature of IgM early B cells isolated from trans-
genic lobes is more similar to IgM+ than IgM cells isolated
from fetal spleen (Figure 4F). These results suggest that the
activity of Cxcl12 overrides the effects of Ccl25 and Scf. From
a hierarchical perspective of functions, Cxcl12 is situated
above Ccl25 and Scf and thus causes the conversion of a
mast cell-specific environment to an environment fostering B
cell development.
T Cell Progenitor Environment
Next, we examined the effects of expressing the Notch ligand
DLL4 in combination with Ccl25 and Scf. Expression of DLL4
together with either Ccl25 or Ccl25 and Scf led to a significant
increase in CD45+CD90+ T cell progenitors in the thymic rudi-
ment (Figures 2C, 2D, 5A, and 5B). This finding supports the
notion that Ccl25 is a key attractor of lymphoid progenitors
(Caldero´n and Boehm, 2011) and demonstrates that DLL4 over-
rides the mast cell progenitor-preference of the Ccl25 and Scf
combination. Under these conditions, the CD90+ cells are
negative for CD4 and CD8 cell-surface marker expression
(Figures 5C and 5D). In keeping with the progenitor status of
CD90+CD4CD8 (DN) cells in the rudiment, the Dß2-Jß2 region
of the T cell receptor (TCR)-b locus was found to be in the germ-
line configuration, accompanied by restricted Dß1-Jß1 rear-
rangements (Figure 5E). Ccl25;Scf;DLL4 epithelia support the
presence and proliferation (Figure 5F) of DN T cell progenitor
cells. Because DLL4 has no apparent chemoattractive proper-
ties, accumulation of T cell precursors requires the presence of
Ccl25, in addition to DLL4; a combination of DLL4 and Scf has
no effect in this regard, suggesting that Ccl25 and Scf attract
different progenitor cell types (Figure 2). Notably, the Notch
ligands Dll3, Jagged1, and Jagged 2 that are expressed in the
Foxn1-deficient epithelium (Figure S1A) are incapable of gener-
ating an environment favorable for T cell development in vivo.
Reconstitution of T Cell Development
Given that Cxcl12 and DLL4 both override the combined effects
of Ccl25 and Scf—the former resulting in a B cell lineage prefer-
ence, the latter in a T cell lineage preference—it was of interest
to examine their functional interactions. For instance, in
Ccl25;Cxcl12;DLL4 and Cxcl12;Scf;DLL4 environments, large
numbers of CD90+ cells are detected (Figures 6A and 6B), the
majority of which also coexpress the CD4 and CD8 coreceptors
(Figure 6C). As expected, double-positive thymocytes carry
variable, diversity, joining element (VDJ) rearrangements at the
Tcrb locus; by contrast, such VDJ rearrangements are absent
in T cell progenitors found in Ccl25;Scf;DLL4 epithelial environ-
ments (Figure 6D), in keeping with their immature phenotype
(Figure 5). Interestingly, CD4/CD8 double-positive (DP) thymo-
cytes can already be observed when epithelial cells express
Cxcl12 and DLL4 only (Figures 6E and 6F); these T cell progen-
itors also carry VDJ rearrangements at the Tcrb locus (Figure 6D),
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Figure 2. Hematopoietic Cells in Transgenic Environments
(A) Enumeration of CD45+ cells at E18.5; the numbers of embryos analyzed for each genotype are indicated at the bottom.
(B) Phenotypic characterization of CD45+ cells according to cell-surface expression of the indicated markers as per cent of total cells.
(C) Pharyngeal region of E13.5-E14.5 double-, triple- and quadruple-transgenics; hematopoietic cells (CD45, red fluorescence) and epithelial cells (CK8, green
fluorescence). The genotypes are indicated at the top of the panels; scale bar, 100 mm.
(D) Thymic lobes of E16.5 embryos, analyzed as in (C) scale bar, 50 mm.
Average values and SEM values are shown. Figure S2 relates to this figure.
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Figure 3. Generation of Mast Cell Environments
(A) Enumeration of hematopoietic cells in transgenic thymic epithelial rudiments at E18.5. The genotypes are indicated at the bottom; + denotes presence of
transgenes, all embryos are Foxn1-deficient (Foxn1/); n, number of embryos analyzed; *p < 0.05; **p < 0.01; ***p < 0.001.
(B and C) Detailed phenotypic characterization of hematopoietic cells in transgenic thymic epithelial rudiments by flow cytometry. In environments expressing
Scf, CD11bCD19CD90 cells are CD117+ST2+. Genotypes are indicated at the top of the panels; ø denotes absence of transgenes.
(D) CD11bCD19CD90CD117+ST2+ cells from transgenic environments contain Giemsa-positive cytoplasmic granules; PMC, peritonealmast cells. Scale bar,
10 mm.
(E) CD45+CD11bCD19CD90 cells from transgenic environments are positive for the proliferation marker Ki-67.
(F) Most CD11bCD19CD90CD117+ST2+ cells from Ccl25;Scf transgenic environments do not express FcεRIa (top panel) and express low levels of CD117.
PMC denotes peritoneal mast cells, CD117 and CD117+ thymocytes are also shown; ctrl denotes staining with isotype-matched irrelevant antibody.
(G) Phenotypic changes of hematopoietic cells after in vitro culture of intact Ccl25;Scf transgenic thymic lobes for 7 days. Notation as in (F).
Average values and SEM values are shown. Dunn’s nonparametric multiple t test was used to examine differences between groups.express TCR-ß at the cell surface (Figure 6G) and actively pro-
liferate (Figure 6H). Gene expression signatures indicate that
these cells resemble DP thymocytes purified from wild-type
thymi (Figure 6I). This finding shows that Cxcl12 has multiple164 Cell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc.functions: it exhibits chemotactic activity, for without this DLL4
cannot recruit hematopoietic cells to the rudiment; Cxcl12 also
promotes lymphoid progenitor development (Janas et al.,
2010; Trampont et al., 2010). In the context of DLL4 function, it
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Figure 4. Generation of B Cell Environments
(A) Enumeration of hematopoietic cells in transgenic thymic epithelial rudiments at E18.5. Asterisks denote significant differences from the values of
nontransgenic controls (*p < 0.05; **p < 0.01; ***p < 0.001).
(B and C) Phenotypic characterization by flow cytometry of hematopoietic cells in transgenic niches; the proportions of cells in each quadrant are indicated.
(D) Expression of the proliferation marker Ki-67 in CD45+CD11bCD19+CD90 cells from the indicated sources.
(E) Maturation of B cells after in vitro culture of intact transgenic lobes for 7 days.
(F) Hierarchical clustering of cell types according to whole genome expression profiles (Agilent). DN3, DN3 wild-type thymocytes (E18.5; linCD117CD25+);
B IgM+ and B IgM, B lineage cells (CD45+B220+CD19+CD11bCD11c) from wild-type fetal spleen separated according to surface IgM expression; B IgM
(in blue font), B lineage cells isolated from E18.5 thymi transgenic for Cxcl12 expression.
Average values and SEM values are shown. Dunn’s nonparametric multiple t test was used to examine differences between groups.directs T cell development, whereas without the presence of
a suitable Notch ligand, it promotes B cell lineage development,
clearly demonstrating how Cxcl12 function is context depen-
dent. In all environments expressing combinations of Cxcl12
and DLL4, the B cell promoting function of Cxcl12 (Nagasawa,
2000) is subordinate to the T cell-promoting function of DLL4,
placing DLL4 at the top of the functional hierarchy of the four
factors studied here; when such lobes are cultured in vivo for
7 days, the number of hematopoietic cells dramatically
decreases (for instance, only 2.1% ± 1.1% [n = 5] of DP thymo-cytes were recovered). We attribute this to the phenomenon
known as ‘‘death-by-neglect’’ (Kisielow and von Boehmer,
1995) because Foxn1-deficient thymic epithelium lacks appre-
ciable levels of MHC expression (Jenkinson et al., 1981; Martinic
et al., 2006) and hence does not support positive selection. In
reaggregate thymus organ cultures consisting of transgenic DP
thymocytes and wild-type thymic epithelium, the transgenic
thymocytes differentiated into CD4+ and CD8+ single-positive
T cells expressing high levels of surface TCR-ß. (Figure 6J).
This indicates that DP thymocytes developing in transgenicCell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc. 165
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Figure 5. Generation of T Cell Environments
(A) Colonization of the epithelial niche (CK8, green) expressing Ccl25, DLL4 and Scf by CD90+ hematopoietic cells (red); E16.5 (one thymic lobe). Scale bar, 50 mm.
(B) Enumeration of T cell progenitors in transgenic thymic epithelial rudiments at E18.5; *p < 0.05; **p < 0.01; ***p < 0.001.
(C and D) Phenotypic characterization by flow cytometry.
(E) Dß-Jß rearrangements in TCR-ß1 (top panel) and TCR-ß2 (bottom panel) genes. Thymocytes of a Rag2-deficient animal were used as negative control, those
from a Foxn1 heterozygous animal as a positive control; a nonspecific fragment is denoted with ns.
(F) Expression of the proliferation marker Ki-67 in CD45+CD11bCD19CD90+ cells from the indicated sources.
Average values and SEM values are shown. Dunn’s nonparametric multiple t test was used to examine differences between groups.lobes are capable of executing the normal program of T cell
differentiation if provided with the necessary extracellular
signals.
Epithelial Scaffolds as Customized Hematopoietic
Environments
Our results indicate that the yield of thymocytes in rudiments
expressing all four factors (Ccl25;Cxcl12;Scf;DLL4 transgenics)
is not significantly different from that obtained with the
Cxcl12;Scf;DLL4 combination (Figures 2 and 6). We also
observed that, in contrast to the Foxn1-sufficient epithelium,166 Cell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc.Foxn1/ epithelial rudiments remain small (Figure 2). Hence,
the total number of cells inhabiting the artificial microenviron-
ments might be constrained by the small size of the rudiment.
Moreover, the epithelial cells in Ccl25;Cxcl12;Scf;DLL4 trans-
genic Foxn1/ animals remain in an undifferentiated state;
notably, there is no evidence for the formation of a medullary
region (Figure S2A). The few MHC class II-positive cells in the
rudiment of Ccl25;Cxcl12;Scf;DLL4 epithelial environments are
dendritic cells (Figure S2A). The thymic rudiment also does
not contain mesenchymal septae that are characteristic of
wild-type thymi (Figure S2C); CD31+ and VE-Cadherin+
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Figure 6. Generation of CD4/CD8 Double-
Positive Thymocytes
(A) Colonization of the epithelial niche (CK8, green)
expressing Ccl25, DLL4, and Scf by CD90+
hematopoietic cells (red); E16.5 (one thymic lobe).
Scale bar, 50 mm.
(B) Enumeration of thymocytes in transgenic
thymic epithelial rudiments at E18.5; *p < 0.05;
**p < 0.01; ***p < 0.001.
(C) Characterization of thymocytes by flow
cytometry.
(D) Amplification of Vß6-Jß1 rearrangements from
genomic DNA of thymic lobes with the indicated
genotypes. ns denotes nonspecific bands.
(E) Colonization of the epithelial niche (CK8, green)
expressing Ccl25, DLL4, and Scf by CD90+
hematopoietic cells (red); E16.5 (one thymic lobe).
Scale bar, 50 mm.
(F) Flow cytometric analysis of CD45+ cells in
thymopoietic niches coexpressing Cxcl12 and
DLL4. The genotypes are indicated at the top of
each panel. The proportion of cells in quadrants is
indicated.
(G) Surface expression of TCR-b on cells from the
indicated sources.
(H) Expression of the proliferation marker Ki-67
in CD45+CD11bCD19CD90+ cells from the
indicated sources.
(I) Hierarchical clustering of cell types according
to whole genome expression profiles (Agilent).
DP, wild-type CD4+CD8+ double-positive cells
isolated from E18.5 thymi; DP (in red font),
CD4+CD8+ double-positive cells isolated from
Cxcl12;DLL4 transgenic E18.5 thymi; SP4, SP8,
CD4+, and CD8+ TCR-ßhi single-positive thymo-
cytes from 2-week-old wild-type thymi. All other
notations are as in Figure 4F.
(J) Schematic of the reaggregation analysis
(left panel; for details see text). Surface expression
of CD4 and CD8 markers according to CD45
allotype (middle panel); surface expression levels
of TCR-b for indicated cell types (right panel).
Average values and SEM values are shown.
Dunn’s nonparametric multiple t test was used to
examine differences between groups.endothelial cells are rare in transgenic thymi (Figures S2C–S2E),
indicating that vascularization is greatly impaired. These find-
ings support the notion that the function of epithelial cells inCell 149, 159–17the artificial hematopoietic environments
appears to be merely that of a cellular
scaffold. Indeed, although mast cell
progenitors and immature B cells
normally develop in the mesenchymal
environment of the bone marrow
(Okayama and Kawakami, 2006; To-
koyoda et al., 2004), our results demon-
strate that they can be trapped and
sustained in an epithelial tissue provided
this compartment supplies an appro-
priate combination of hematopoietic
factors.As shown above, customized microenvironments expressing
combinations of two or three factors can be constructed to
accommodate different progenitor cell types, mast cell, B cell,2, March 30, 2012 ª2012 Elsevier Inc. 167
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Figure 7. Hematopoietic Properties of Arti-
ficial Epithelial Environments
(A) Yield of different progenitor types in selected
types of transgenic environments. Logarithmic
scale. Yellow, mast cell progenitors; blue; B cell
progenitors; pink, T cell progenitors; red, immature
T cells; genotypes are indicated at the bottom.
(B) Venn diagram illustrating the functional char-
acteristics of environments expressing different
combinations of factors functions and their
hierarchical relationships. Colors denote the
predominant progenitor cell type (code as in A);
green color indicates lack of or nonspecific
hematopoietic activity.
(C) Transfating assay. Donor cells were purified
by flow cytometry and incubated in vitro in the
presence of a noncognate artifical host environment
for 7 days; subsequently, cells of the desired
phenotype were isolated by flow cytometry and
subjected to genotyping (a schematic of the exper-
iment is shown in the top panel). The source of DNA
for PCR-based genotyping is indicated (bottom
panel); H20 denotes no-template control. Genotyp-
ing results fromoneof two independentexperiments
are shown; the yield of B220+CD19+ cells after
in vitro culturewas 676 and 1,020 cells, respectively.
Average values and SEM values are shown.and T cell progenitors (Figure 7A). The results described here
also reveal the synergistic, context-dependent, and hierarchical
nature of the functional interactions of Ccl25, Cxcl12, Scf, and
DLL4. The surprisingly simple logic of interactions revealed
by our experiments can be best visualized in a Venn diagram
(Figure 7B), illustrating that Ccl25 is at the foot and DLL4 at the
top of the in vivo functional hierarchy.
Next, we examined whether the transfer of different progenitor
populations to noncognate artificial environments was accom-
panied by changes in their phenotypes. Owing to the phenom-
enon of ‘‘death-by-neglect’’ occurring in synthetic environments
during in vitro culture (see above), the in vitro conversion to
DP thymocytes could not be reliably examined. By contrast,
the survival and/or further development of B cells was not
impaired in organ cultures (Table S1). When cocultured with
B cell supporting transgenic thymic lobes, CD90+ progenitor
cells isolated from Ccl25, Ccl25;DLL4, or Ccl25;DLL4;Scf
transgenic thymi did not convert to a B220+CD19+ B cell pheno-
type (Table S2). This observation is consistent with previous
findings that CD90+ cells from fetal blood lack B cell potential
(Rodewald et al., 1994); it supports the view that, once exposed
to DLL4, thymocytes lose B cell potential (Benz and Bleul, 2005;
Sambandam et al., 2005) and is compatible with the dominant
role of DLL4 in shaping the lineage identity of progenitor cells
in vivo (Figure 7B). By contrast, in vitro coculture of the168 Cell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc.CD11bCD19CD90CD117+ST2+ pro-
genitor population—isolated from Ccl25;
Scf artificial environments—with Ccxl12-
transgenic thymi (that is, in a B cell poietic
environment) revealed the presence of B
cell potential in the mast cell precursorpopulation (Figure 7C), suggesting the possibility of develop-
mental plasticity and/or heterogeneity.
DISCUSSION
The Functional Logic of Effector Molecule Interactions
Our in vivo engineering approach directly reveals several key
functional characteristics of thymopoietic environments. The
factors analyzed here act in a modular fashion because each
factor alone exhibits a distinct kind of hematopoietic activity;
compare, for instance, the predominantly chemotactic function
of Ccl25 (Kunkel and Butcher, 2002) to the mast cell-specific
activity of Scf (Okayama and Kawakami, 2006). The factors
also synergize, as shown for example by the numerical increase
in mast cell progenitors in an Scf-expressing niche upon addi-
tional supply of Ccl25. Context dependence is exemplified by
the different roles of Cxcl12, which supports B cell precursors
(Nagasawa, 2000) in the absence of the Notch ligand DLL4,
and T cell precursors (Janas et al., 2010; Trampont et al., 2010)
in its presence. The hierarchical nature of their functional inter-
actions is best illustrated by the dominant T cell promoting func-
tion of the Notch ligand DLL4; among the four factors studied
here, the chemokine Ccl25 is positioned at the foot of this func-
tional hierarchy. Our experiments also reveal that few factors
suffice to generate functionally distinct microenvironments,
some supporting myeloid cell types, others promoting the pres-
ence of cells of lymphoid lineages.
The presence of different hematopoietic progenitor cell types
in the synthetic environments studied here could be the result
of selective attraction of lineage-committed progenitors from
the blood and their differential survival and/or expansion,
lineage-specific differentiation of multipotent precursors, or
even fate conversion of lineage-committed hematopoietic cells.
Resemblance of Phenotypes in Artificial Environments
to Loss-of-Function Phenotypes
How similar to physiological situations are the synthetic environ-
ments described here? In qualitative terms, the phenotypes
observed here are compatible with those observed in mice
deficient for Ccl25, Cxcl12, Scf, or Dll4, as detailed below. The
differences are quantitative, as all synthetic environments
contain substantially fewer hematopoietic cells than the corre-
sponding Foxn1-sufficient thymic microenvironments lacking
the function of any one factor. However, this can be, at least in
part, explained by the fact that the absence of Foxn1 compro-
mises the proliferation of thymic epithelial cells (Blackburn
et al., 1996; Nehls et al., 1996), resulting in fewer epithelial cells
per rudiment. Therefore, the small sizes of synthetic environ-
ments described here significantly limit the number of hemato-
poietic progenitors that can be accommodated in them.
Mice lacking the genes encoding Ccl25, or the corresponding
Ccr9 receptor, have no appreciable phenotype in the context of
T cell development at late stages of gestation (Benz et al., 2004;
Liu et al., 2006; Wurbel et al., 2001). Indeed, environments
expressing the combination of Cxcl12, Scf, and DLL4 are indis-
tinguishable from those expressing all four factors, both in
terms of the distribution of cell types and the number of cells
present in the niche. Moreover, absence of Ccl25 does not alter
the composition of cells, strongly suggesting that Ccl25 and
its receptor Ccr9 only mediate chemotaxis in the context of
hematopoietic differentiation (Caldero´n and Boehm, 2011).
Mice lacking Scf have a small thymus, but T cell development
is not impaired in qualitative terms (Rodewald et al., 1995); this
phenotype is mirrored in Ccl25;Cxcl12;DLL4 triple transgenic
environments. Mice lacking Cxcl12 exhibit slight reductions in
thymocyte numbers (Ara et al., 2003); this effect is in part due
to the role of Cxcr4-signaling during b-selection of T cell devel-
opment (Janas et al., 2010; Trampont et al., 2010). The pheno-
type observed in the Ccl25;DLL4;Scf combination studied here
is compatible with theCxcl12/Cxcr4 loss-of-function phenotype.
B cells predominate in the thymus of mice lackingDLL4 in thymic
epithelial cells (Hozumi et al., 2008; Koch et al., 2008), which is
also observed in Ccl25;Cxcl12;Scf environments. Interestingly,
the presence of B cells in Dll4-deficient thymi has previously
been interpreted as an indication that B cell development is
the default mode of differentiation for the physiological hemato-
poietic precursors present in the thymus, unless they receive
a Notch1-mediated signal. Our results suggest, however, that
B cell development only takes place when Cxcl12 is present.
Hence, this observation identifies Cxcl12 as a permissive factor
for the presence of B cells in the thymus and suggests genetic
interactions between Cxcr4 and Notch signaling. Indeed, when
Cxcl12 is absent, immature mast cells rather than B cell pro-genitors constitute the dominant population. This finding also
provides an explanation for the observation that only small
numbers of thymocytes have fate-switched to the B cell and
dendritic cell lineages in the absence of Notch1-mediated
signaling in hematopoietic cells (Feyerabend et al., 2009). The
present results also underscore the notion that Dll4 is necessary
for T cell differentiation and that the other Notch ligands still
expressed in the Foxn1/ thymic epithelium are incapable of
substituting for Dll4. Because of the close resemblance of
phenotypes obtained with the various artificial environments to
the respective single factor knockout situations, we conclude
that the functional characteristics of the four factors emerging
from our combinatorial analysis are physiologically relevant.
Therefore, predictions can be made for the thymus phenotype
of mutant mice deficient for two or more of the factors studied
here. For instance, in mice lacking both Cxcl12 and Dll4 in the
thymic epithelium, a situation not previously studied using
loss-of-function approaches, cells in the thymus should consist
primarily of mast cell progenitors.
Relevance of Epithelial Components to the Evolution
of Thymopoiesis
A surprising result of our study is the finding that the expression
of only two factors, Cxcl12 and DLL4, suffices to support T cell
differentiation to the CD4/CD8 double-positive stage, a key
checkpoint of intrathymic development. This observation
provides an interesting test case for a hypothesis concerning
the evolutionary sequence of events leading to the emergence
of thymopoiesis in vertebrates (Bajoghli et al., 2009; Boehm,
2011). This hypothesis posits that, in addition to a general acces-
sibility for hematopoietic cells, the exposure of precursors to
appropriate Notch ligands in the pharyngeal epithelium via
direct cell-cell contacts depends on the coexpression of chemo-
kines emanating from this site. In jawed vertebrates, this function
is attributed to Ccl25 (Bajoghli et al., 2009; Caldero´n and Boehm,
2011). Our present results suggest that Cxcl12, an evolutionarily
more ancient chemokine than Ccl25 (Bajoghli et al., 2009), can
substitute for Ccl25, perhaps explaining the presence of
T-lineage cells in the thymus equivalent of jawless vertebrates
(Bajoghli et al., 2011). Therefore, the exact molecular identity
of a chemotactic cue emanating from a thymopoietic micro-
environment may be irrelevant, as long as it mediates the occur-
rence of crucial Notch/Dll interaction.
Conclusions
Our study demonstrates that epithelial cells can be engineered
in vivo to support hematopoietic cells of different lineages and
of various stages in the differentiation pathways. Surprisingly
few factors suffice to generate functionally distinct environ-
ments; for instance, just one additional factor is sufficient to
turn a myeloid into a B or T lineage lymphoid microenvironment.
This finding provides an explanation as to how the lineage-
specific spatial separation of differentiation pathways in
a morphologically inconspicuous physiological microenviron-
ment, such as the bone marrow, might be achieved: as demon-
strated here, differential expression of only one or two stromal
factors suffices to yield dramatically different outcomes. Hence,
endogenous environments underlying the stepwise progressionCell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc. 169
along stereotyped differentiation pathways in hematopoietic
tissues can only be identified by high-resolution and multipara-
metric in situ analysis of protein/gene expression. The pheno-
types of synthetic environments such as those described here
provide invaluable information for guiding these studies and
should also facilitate efforts aimed at engineering hematopoietic
progenitor cell niches ex vivo (Peerani and Zandstra, 2010).EXPERIMENTAL PROCEDURES
Animals
Foxn1:Ccl25, Foxn1:Cxcl12, Foxn1:Scf; Foxn1:DLL4 transgenic mice were
generated by cloning a 27,970 bp Foxn1 promoter fragment (Y12488, nucleo-
tides [nt] 5680–33650) upstream of cDNA fragments (Ccl25: nt 119–553
in NM_009138; Cxcl12: nt 70–497 in NM_001012477.2; Scf: nt 77–1355 in
BC011322 [membrane-bound form]; human DLL4: nt 311–2432 in
NM_019074); a bovine growth hormone polyadenylation sequence was
inserted downstream of the cDNA fragments (details of the cloning strategies
and the complete nucleotide sequences of transgenic constructs are available
upon request). Conditions for genotyping are detailed in the Extended Exper-
imental Procedures. Animal experiments were approved by the institutional
review board and the local government.mRNA In Situ Hybridization
In situ hybridizations were carried out on paraffin-embedded sections using
digoxigenin-labeled riboprobes generated with the DIG RNA labeling Kit
according to the manufacturer’s recommendations (Boehringer Mannheim)
from PCR products cloned into pGEM-T Easy (Promega). Control hybridiza-
tions were conducted with sense riboprobes; no signals were detected.
Probes are listed in the Extended Experimental Procedures.Flow Cytometric Analysis and Cell Sorting
Embryonic thymi were carefully minced with two thin forceps to prepare
single-cell suspensions for subsequent staining and flow cytometry. Anti-
bodies (Abs) are listed in the Extended Experimental Procedures. Analytical
cytometry was performed using an LSRII apparatus; cell sorting was done
using a FACSAria instrument (BD Biosciences). Mast cells were sorted by
flow cytometry, cytospun, fixed in methanol, and stained with Giemsa staining
solution.Immunohistochemistry
E13.5–E14.5 and E16.5–17.5 embryos were embedded in OCT and snap-
frozen. Transversal sections (thickness 7 mm) were fixed in acetone/methanol
(3:1; v/v). Abs are listed in the Extended Experimental Procedures. Fluoro-
chrome-labeled Abs were detected using a Zeiss AxioImager.Z1 microscope
with ApoTome slider and Axiovision 4.8 software.TCR-b Rearrangements
The assay was done as described (Kawamoto et al., 2000). Cell lysates were
directly used as templates for PCR amplification (King et al., 2002; Terszowski
et al., 2006). Primers are listed in the Extended Experimental Procedures.ELISA
Serum and plasma levels of Cxcl12 and Scf were determined using mouse
Quantikine Immunoassays (R&D Systems).Gene Expression Analysis
RNA was isolated from cells purified by flow cytometry and hybridized to
Agilent Whole Mouse Genome Oligo Microarrays (8 3 60K; Miltenyi Biotec,
Cologne, Germany). Expression data were data subjected to hierarchical
clustering (for details, see the Extended Experimental Procedures) and sub-
sequently depicted in heatmap format (GEO accession number GSE33268).170 Cell 149, 159–172, March 30, 2012 ª2012 Elsevier Inc.qRT-PCR
Quantitative RT-PCR was carried out using the QPCR SYBR kit (Thermo
Scientific) using cDNA prepared from purified thymic epithelial cells of
wild-type and transgenic thymi as detailed in the Extended Experimental
Procedures.
FTOC
Intact thymic lobes were cultured as described in the Extended Experimental
Procedures.
RTOC
The fetal thymus reaggregation procedure was carried out as detailed in the
Extended Experimental Procedures.
Fate Conversion Assay
Phenotypic stability of cell populations was assayed as described in the
Extended Experimental Procedures.
Statistical Analysis
Average values and standard error of mean values are shown. Dunn’s
nonparametric multiple t test was used to examine differences between
groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
three figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2012.01.049.
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